Recent advance in treatment of Meige syndrome
10.3760/cma.j.issn.1671-8925.2019.11.021
- VernacularTitle:Meige综合征的治疗进展
- Author:
Wentao ZHENG
1
;
Ruen LIU
Author Information
1. 北京大学人民医院神经外科
- Keywords:
Meige syndrome;
Dystonia;
Botulinum toxin;
Deep brain stimulation
- From:
Chinese Journal of Neuromedicine
2019;18(11):1180-1183
- CountryChina
- Language:Chinese
-
Abstract:
Meige syndrome is a rare segmental craniocervical dystonia, mainly characterized by blepharospasm and involuntary contraction of jaw and neck muscles, which will seriously decrease the patient's quality of life. The etiology and pathogenesis of the disease remain unclear, despite of some progress having been made in the relevant studies. Current treatments include drug therapy, botulinum toxin A injection and surgical treatment. In this article, the pathogenesis, clinical manifestations and treatment of Meige syndrome will be briefly reviewed.
